Using a new method of directed human gene evolution that we have developed in our laboratory, we previously described the isolation and characterisation of a dCK mutant, named G12, that induces sensitisation of cancer cells to treatment with the anticancer compound gemcitabine [34]. This evidence concerns the gene DCK and cancer.